Ceramide (Lysosomal) (Cer)

Lysosomal ceramide is a bioactive sphingolipid that serves as a central hub in sphingolipid metabolism and a potent mediator of cellular stress responses [2, 4]. It is primarily generated within the lysosome through the action of acid sphingomyelinase (ASM) on sphingomyelin or via the degradation of complex glycosphingolipids [2]. As a signaling molecule, lysosomal ceramide promotes programmed cell death (apoptosis), regulates autophagy, and influences membrane biophysical properties, such as the formation of ceramide-rich platforms for receptor clustering [2, 4]. Dysregulation of lysosomal ceramide levels is implicated in several pathologies; for instance, its accumulation due to acid ceramidase deficiency causes Farber disease, a rare lysosomal storage disorder [1]. Conversely, ceramide levels are often suppressed in various cancers, allowing malignant cells to evade apoptosis and proliferate [4]. Therapeutic strategies targeting this lipid include enzyme replacement therapies like olipudase alfa, which restores the metabolic pathway in Niemann-Pick disease [5]. Additionally, functional inhibitors of acid sphingomyelinase (FIASMAs), such as certain antidepressants, are used to modulate ceramide-driven inflammation and have been investigated for their role in treating major depression and viral infections [3]. Research also explores the use of ceramide nanoliposomes as a direct pro-apoptotic treatment for solid tumors [4].

Other names

N-acylsphingosineLysosomal ceramide poolCeramide

Modulation of lysosomal ceramide levels through enzyme replacement therapy (e.g., olipudase alfa) to restore metabolic flux, or via functional inhibition of acid sphingomyelinase (FIASMAs) to reduce ceramide-mediated signaling and membrane remodeling [3, 5].